Neuronal calcium channels blocker, ziconotide (ɷ-conotoxin MVIIA), reverses morphine withdrawal-induced memory impairments via alteration in hippocampal NMDA receptor expression in rats

References

• Anneken, J., and Gudelsky, G., 2012. MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus. Neuropharmacology, 63 (6), 1022–1027.
   PubMed Web of Science ®Google Scholar
• Antunes, M., and Biala, G., 2012. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cognitive processing, 13 (2), 93–110.
   PubMed Web of Science ®Google Scholar
• Bao, G., Kang, L., and Li, H., 2007. Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat. Neuropsychopharmacology, 32 (8), 1738–1749.
   PubMed Web of Science ®Google Scholar
• Berberich, S., et al., 2005. Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. Journal of neuroscience, 25 (29), 6907–6910.
   PubMed Web of Science ®Google Scholar
• Berman, R.F., Verweij, B.H., and Muizelaar, J.P., 2000. Neurobehavioral protection by the neuronal calcium channel blocker ziconotide in a model of traumatic diffuse brain injury in rats. Journal of neurosurgery, 93 (5), 821–828.
   PubMed Web of Science ®Google Scholar
• Bisaga, A., et al., 2001. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in human. Psychopharmacology, 157 (1), 1–10.
   PubMed Web of Science ®Google Scholar
• Bobich, J.A., Zheng, Q., and Campbell, A., 2004. Incubation of nerve endings with a physiological concentration of Abeta1-42 activates CaV2.2(N-Type)-voltage operated calcium channels and acutely increases glutamate and noradrenaline release. Journal of Alzheimer's disease, 6 (3), 243–255.
   PubMed Web of Science ®Google Scholar
• Bozorgi, H., Jahanian-Najafabadi, A., and Rabbani, M., 2016. The effect of intrathecal administration of the N-type calcium channels antagonist, ɷ-Conotoxin MVIIA, on attenuating the spontaneous and naloxone-precipitated morphine withdrawal in rats. Toxin reviews, 35 (1-2), 33–37.
   Web of Science ®Google Scholar
• Choi, D.W. 1994. Calcium and excitotoxic neuronal injury. Annals of the New York academy of sciences, 747, 162–171.
   PubMed Web of Science ®Google Scholar
• Choi, D.W., Maulucci-Gedde, M., and Kriegstein, A.R., 1987. Glutamate neurotoxicity in cortical cell culture. Journal of neuroscience, 7 (2), 357–368.
   PubMed Web of Science ®Google Scholar
• Chou, W.B., et al., 2002. M2 muscarinic receptor of spinal cord mediated increase of nNOS expression in locus coeruleus during morphine withdrawal. Acta pharmacologica sinica, 23 (8), 691–697.
   PubMed Web of Science ®Google Scholar
• Clements, M.P., Rose, S.P., and Tiunova, A., 1995. Omega-Conotoxin GVIA disrupts memory formation in the day-old chick. Neurobiology of learning and memory, 64 (3), 276–284.
   PubMed Web of Science ®Google Scholar
• Dong, Z., et al., 2008. Morphine withdrawal affects both delayed-escape behavior in Morris water maze and hippocampal NR2A/2B expression ratio. Brain research, 1207, 164–173.
   PubMed Web of Science ®Google Scholar
• Dougherty, K., et al., 1996. Acquisition of a Morris water maze task is impaired during early but not late withdrawal from morphine. Pharmacology biochemistry and behaviour, 55 (2), 227–235.
   PubMed Web of Science ®Google Scholar
• Ennaceur, A., and Delacour, J., 1988. A new one-trial test for neurobiological studies of memory in rats. Behavioural brain research, 31 (1), 47–59.
   PubMed Web of Science ®Google Scholar
• Ersche, K.D., et al., 2006. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology, 31 (5), 1036–1047.
   PubMed Web of Science ®Google Scholar
• Evans, R.M., and Zamponi, G.W., 2006. Presynaptic Ca2+ channels-integration centers for neuronal signaling pathways. Trends in neurosciences, 29 (11), 617–624.
   PubMed Web of Science ®Google Scholar
• Gellert, V.F., and Holtzman, S.G., 1978. Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. Journal of pharmacology and experimental therapeutics, 205 (3), 536–546.
   PubMed Web of Science ®Google Scholar
• Gerra, G., et al., 1998. Regional cerebral blood flow and comorbid diagnosis in abstinent opioid addicts. Psychiatry research, 83 (2), 117–126.
   PubMed Web of Science ®Google Scholar
• Harris, G.C. and Aston-Jones, G., 2003. Altered motivation and learning following opiate withdrawal: evidence for prolonged dysregulation of reward processing. Neuropsychopharmacology, 28 (5), 865–871.
   PubMed Web of Science ®Google Scholar
• Kornhuber, J. and Weller, M., 1997. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biological psychiatry, 41 (2), 135–144.
   PubMed Web of Science ®Google Scholar
• Krystal, J.H., et al., 1995. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT). American journal of drug and alcohol abuse, 21 (1), 47–63.
   PubMed Web of Science ®Google Scholar
• Liu, L., et al., 2004. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science, 304 (5673), 1021–1024.
   PubMed Web of Science ®Google Scholar
• Lu, G., et al., 2010. Chronic morphine treatment impaired hippocampal long-term potentiation and spatial memory via accumulation of extracellular adenosine acting on adenosine A1 receptors. Journal of neuroscience, 30 (14), 5058–5070.
   PubMed Web of Science ®Google Scholar
• McCardle, K., et al., 2004. Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology, 173 (3-4), 434–439.
   PubMed Web of Science ®Google Scholar
• McGivern, J.G., 2007. Ziconotide: a review of its pharmacology and use in the treatment of pain. Neuropsychiatric disease and treatment, 3 (1), 69–85.
   PubMedGoogle Scholar
• Mestre, C., et al., 1994. A method to perform direct transcutaneous intrathecal injection in rats. Journal of pharmacological and toxicological methods, 32 (4), 197–200.
   PubMed Web of Science ®Google Scholar
• Miladi-Gorji, H., Rashidy-Pour, A., and Fathollahi, Y., 2008. Effects of morphine dependence on the performance of rats in reference and working versions of the water maze. Physiology and behavior, 93 (3), 622–627.
   PubMed Web of Science ®Google Scholar
• Miladi-Gorji, H., et al., 2011. Voluntary exercise ameliorates cognitive deficits in morphine dependent rats: the role of hippocampal brain-derived neurotrophic factor. Neurobiology of learning and memory, 96 (3), 479–491.
   PubMed Web of Science ®Google Scholar
• Nimmrich, V., and Eckert, A., 2013. Calcium channel blockers and dementia. British journal of pharmacology, 169 (6), 1203–1210.
   PubMed Web of Science ®Google Scholar
• Niu, L., et al., 2009. Impaired in vivo synaptic plasticity in dentate gyrus and spatial memory in juvenile rats induced by prenatal morphine exposure. Hippocampus, 19 (7), 649–657.
   PubMed Web of Science ®Google Scholar
• Olney, J., et al., 1991. NMDA antagonist neurotoxicity: mechanism and prevention. Science, 254 (5037), 1515–1518.
   PubMed Web of Science ®Google Scholar
• Pace-Schott, E.F., et al., 2008. Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. American journal of drug and alcohol abuse, 34 (1), 109–121.
   PubMed Web of Science ®Google Scholar
• Quevedo, J., et al., 1998. L-type voltage-dependent calcium channel blocker nifedipine enhances memory retention when infused into the hippocampus. Neurobiology of learning and memory, 69 (3), 320–325.
   PubMed Web of Science ®Google Scholar
• Rabbani, M., Hajhashemi, V., and Mesripour, A., 2009. Increase in brain corticosterone concentration and recognition memory impairment following morphine withdrawal in mice. Stress, 12 (5), 451–456.
   PubMedGoogle Scholar
• Rubio, M., et al., 2011. Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. Plos one, 6, 23–90.
   Web of Science ®Google Scholar
• Spain, J.W., and Newsom, G.C., 1991. Chronic opioids impair acquisition of both radial maze and Y-maze choice escape. Psychopharmacology, 105 (1), 101–106.
   PubMed Web of Science ®Google Scholar
• Tanganelli, S., et al., 1991. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neuroscience letters, 122 (2), 270.
   PubMed Web of Science ®Google Scholar
• Tarragon, L., et al., 2012. The radial arm maze (RAM) for the evaluation of working and reference memory deficits in the diurnal rodent octodondegus. Proceedings of measuring behaviour, 31, 98–100.
   Google Scholar
• Twede, V., et al., 2009. Neuroprotective and cardioprotective conopeptides: An emerging class of drug leads. Current opinion in drug discovery and development, 12 (2), 231–239.
   PubMedGoogle Scholar
• Valverde, O., and Roques, B.P., 1998. Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in rats. Neuroscience letters, 244 (1), 37–40.
   PubMed Web of Science ®Google Scholar
• Vanegas, H., and Schaible, H.G., 2004. Descending control of persistent pain: inhibitory or facilitatory? Brain research reviews, 46 (3), 295–309.
   PubMedGoogle Scholar
• Vaseghi, G., Hajhashemi, V., and Rabbani, M., 2014. The effect of nimodipine on memory loss following naloxone-induced morphine withdrawal in object recognition. Research in pharmaceutical sciences, 9 (6), 445–451.
   PubMedGoogle Scholar
• Vaseghi, G., Rabbani, M., and Hajhashemi, V., 2012. The effect of nimodipine on memory impairment during spontaneous morphine withdrawal in mice: corticosterone interaction. European journal of pharmacology, 695 (1–3), 83–87.
   PubMed Web of Science ®Google Scholar
• Wareing, M., et al., 2007. Information processing speed in ecstasy (MDMA) users. Human psychopharmacology, 22 (2), 81–88.
   PubMed Web of Science ®Google Scholar
• Winquist, R.J., Pan, J.Q., and Gribkoff, V.K., 2005. Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain. Biochemical pharmacology, 70 (4), 489–499.
   PubMed Web of Science ®Google Scholar